CLL, RELAPSED
Clinical trials for CLL, RELAPSED explained in plain language.
Never miss a new study
Get alerted when new CLL, RELAPSED trials appear
Sign up with your email to follow new studies for CLL, RELAPSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cholesterol drug shows promise in early leukemia trial
Disease control CompletedThis early-phase trial tested adding the cholesterol drug pitavastatin to the standard leukemia medicine venetoclax in 6 people with chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). The main goal was to find a safe dose and check for side effects. Researchers a…
Matched conditions: CLL, RELAPSED
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 26, 2026 15:42 UTC
-
CLL patients left in the dark: study maps treatment gaps after key drug fails
Knowledge-focused CompletedThis study looked at 152 adults with chronic lymphocytic leukemia (CLL) whose cancer stopped responding to a class of drugs called BTK inhibitors (like ibrutinib) and, in some cases, also to venetoclax. The goal was to understand what treatments doctors used next and how well the…
Matched conditions: CLL, RELAPSED
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC